Sphingolipids in neuroinflammation: a potential target for diagnosis and therapy
Open accessAbstract
Sphingolipids are ubiquitous building blocks of eukaryotic cell membranes that function as signaling molecules for regulating a diverse range of cellular processes, including cell proliferation, growth, survival, immune-cell trafficking, vascular and epithelial integrity, and inflammation. Recently, several studies have highlighted the pivotal role of sphingolipids in neuroinflammatory regulation. Sphingolipids have multiple functions, including induction of the expression of various inflammatory mediators and regulation of neuroinflammation by directly effecting the cells of the central nervous system. Accumulating evidence points to sphingolipid engagement in neuroinflammatory disorders, including Alzheimer's and Parkinson's diseases. Abnormal sphingolipid alterations, which involves an increase in ceramide and a decrease in sphingosine kinase, are observed during neuroinflammatory disease. These trends are observed early during disease development, and thus highlight the potential of sphingolipids as a new therapeutic and diagnostic target for neuroinflammatory diseases. [BMB Reports 2020; 53(1): 28-34].
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Ceramides are bioactive sphingolipids involved in cell signaling, apoptosis, and membrane structure, and play a critical role in neurodegenerative diseases like Alzheimer's disease.
“Cers are bioactive sphingolipids involved in cell signaling, apoptosis, and membrane structure, playing a critical role in neurodegenerative diseases like AD. 22 , 23”
From Protective mechanisms against Alzheimer's disease in APOE3‐Christchurch homozygous astrocytes (2025) · cites this paper as [23]
The Ceramide section describes ceramide’s effects on neuronal cell death, apoptosis, and inflammatory signaling. The Alzheimer’s disease section links altered ceramide levels and metabolism to AD pathogenesis. The cited passages do not establish the claimed role of ceramides in membrane structure. (LLM, conf=0.82)
Experimental — accuracy not yet measuredAbnormal sphingolipid levels are linked to neuroinflammatory disorders.
“These abnormal changes in sphingolipid levels have been closely linked to neuroinflammatory disorders, as they play a crucial role in cell signaling and are, therefore, frequently discussed as potential therapeutic targets (45, 46).”
From Reducing microglial lipid load enhances β amyloid phagocytosis in an Alzheimer’s disease mouse model (2025) · cites this paper as [46]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Poewe, W., Seppi, K., Tanner, C. M., Halliday, G. M., Brundin, P., Volkmann, J., Schrag, A.-E., & Lang, A. E. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.13 · Cited by 5,415 · see citing works
Pro-resolving lipid mediators are leads for resolution physiology
Serhan, C. N. (2014) · Nature · doi:10.1038/nature13479 · Cited by 3,041 · see citing works
Immune attack: the role of inflammation in Alzheimer disease
Heppner, F. L., Ransohoff, R. M., & Becher, B. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3880 · Cited by 2,134 · see citing works
Sphingolipids and their metabolism in physiology and disease
Hannun, Y. A., & Obeid, L. M. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.107 · Cited by 2,066 · see citing works
Microglia emerge as central players in brain disease
Salter, M. W., & Stevens, B. (2017) · Nature Medicine · doi:10.1038/nm.4397 · Cited by 1,767 · see citing works
Sphingolipid metabolites in inflammatory disease
Maceyka, M. W., & Spiegel, S. (2014) · Nature · doi:10.1038/nature13475 · Cited by 1,284 · see citing works
Proresolving Lipid Mediators and Mechanisms in the Resolution of Acute Inflammation
Buckley, C. D., Gilroy, D. W., & Serhan, C. N. (2014) · Immunity · doi:10.1016/j.immuni.2014.02.009 · Cited by 811 · see citing works
The outs and the ins of sphingosine-1-phosphate in immunity
Spiegel, S., & Milstien, S. (2011) · Nature Reviews Immunology · doi:10.1038/nri2974 · Cited by 810 · see citing works
Sphingolipid and Glycosphingolipid Metabolic Pathways in the Era of Sphingolipidomics
Merrill, A. H. (2011) · Chemical Reviews · doi:10.1021/cr2002917 · Cited by 781 · see citing works
TREM2 — a key player in microglial biology and Alzheimer disease
Ulland, T. K., & Colonna, M. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0072-1 · Cited by 735 · see citing works
Circuit Mechanisms of Parkinson’s Disease
McGregor, M. M., & Nelson, A. (2019) · Neuron · doi:10.1016/j.neuron.2019.03.004 · Cited by 632 · see citing works
Energy metabolism and inflammation in brain aging and Alzheimer’s disease
Yin, F., Sancheti, H., Patil, I., & Cadenas, E. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.04.200 · Cited by 538 · see citing works
Update on Alzheimer’s Disease Therapy and Prevention Strategies
Graham, W. V., Bonito-Oliva, A., & Sakmar, T. P. (2017) · Annual Review of Medicine · doi:10.1146/annurev-med-042915-103753 · Cited by 506 · see citing works
CNS inflammation and neurodegeneration
Chitnis, T., & Weiner, H. L. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90609 · Cited by 484 · see citing works
Microglia and Astrocytes in Alzheimer's Disease: Implications for Therapy
Fakhoury, M. (2017) · Current Neuropharmacology · doi:10.2174/1570159x15666170720095240 · Cited by 482 · see citing works
Bidirectional Microglia–Neuron Communication in Health and Disease
Szepesi, Z., Manouchehrian, O., Bachiller, S., & Deierborg, T. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00323 · Cited by 459 · see citing works
Sphingosine 1-phosphate and ceramide 1-phosphate: expanding roles in cell signaling
Chalfant, C. E., & Spiegel, S. (2005) · Journal of Cell Science · doi:10.1242/jcs.02637 · Cited by 446 · see citing works
Schwartz, M., & Baruch, K. (2014) · The EMBO Journal · doi:10.1002/embj.201386609 · Cited by 349 · see citing works
Sphingolipids: regulators of crosstalk between apoptosis and autophagy
Young, M. M., KESTER, M. A., & Wang, H. (2012) · Journal of Lipid Research · doi:10.1194/jlr.r031278 · Cited by 329 · see citing works
Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate
Xu, X.-M., Sansores-García, L., Chen, X.-M., Matijevic‐Aleksic, N., Du, M., & Wu, K. K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.9.5292 · Cited by 301 · see citing works
Czubowicz, K., Jęśko, H. M., Wencel, P. L., Lukiw, W. J., & Strosznajder, R. P. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1448-3 · Cited by 296 · see citing works
Sphingolipids in inflammation: pathological implications and potential therapeutic targets
Nixon, G. F. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00281.x · Cited by 286 · see citing works
Therapeutic strategies for Parkinson disease: beyond dopaminergic drugs
Charvin, D., Medori, R., Hauser, R. A., & Rascol, O. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.136 · Cited by 285 · see citing works
Arcuri, C., Mecca, C., Bianchi, R., Giambanco, I., & Donato, R. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00191 · Cited by 279 · see citing works
Mitchell, J. A., & Warner, T. D. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1929 · Cited by 279 · see citing works
Immune cells and CNS physiology: Microglia and beyond
Norris, G. T., & Kipnis, J. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20180199 · Cited by 274 · see citing works
Ceramide function in the brain: when a slight tilt is enough
Mencarelli, C., & Martínez‐Martínez, P. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1038-x · Cited by 261 · see citing works
Aspirin-like Molecules that Covalently Inactivate Cyclooxygenase-2
Kalgutkar, A. S. S., Crews, B. C., Rowlinson, S. W., Garner, C., Seibert, K., & Marnett, L. J. (1998) · Science · doi:10.1126/science.280.5367.1268 · Cited by 257 · see citing works
COX-2-derived endocannabinoid metabolites as novel inflammatory mediators
Alhouayek, M., & Muccioli, G. G. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.03.001 · Cited by 253 · see citing works
Jazvinšćak Jembrek, M., Hof, P. R., & Šimić, G. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/346783 · Cited by 244 · see citing works
Kotilinek, L., Westerman, M. A., Wang, Q., Panizzon, K. L., Lim, G. P., Simonyi, Á., Lesné, S., Falinska, A. M., Younkin, L. H., Younkin, S. G., et al. (2008) · Brain · doi:10.1093/brain/awn008 · Cited by 220 · see citing works
Control of autoimmune CNS inflammation by astrocytes
Rothhammer, V., & Quintana, F. J. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0515-3 · Cited by 214 · see citing works
Phospholipids and Alzheimer’s Disease: Alterations, Mechanisms and Potential Biomarkers
Košiček, M., & Hecimovic, S. K. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14011310 · Cited by 213 · see citing works
Pro-Resolving Lipid Mediators Improve Neuronal Survival and Increase Aβ42 Phagocytosis
Zhu, M., Wang, X., Hjorth, E., Colas, R. A., Schroeder, L., Granholm, A.-C., Serhan, C. N., & Schultzberg, M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9544-0 · Cited by 204 · see citing works
The Threshold Theory for Parkinson's Disease
Engelender, S., & Ole Isacson, A. (2016) · Trends in Neurosciences · doi:10.1016/j.tins.2016.10.008 · Cited by 194 · see citing works
Mesa-Herrera, F., Taoro‐González, L., Valdés‐Baizabal, C., Díaz, M. L., & Marín, R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153810 · Cited by 182 · see citing works
Early and Late CNS Inflammation in Alzheimer’s Disease: Two Extremes of a Continuum?
Cuello, A. C. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.07.005 · Cited by 164 · see citing works
Pahan, K., Sheikh, F. G., Khan, M., Namboodiri, A. M., & Singh, I. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.5.2591 · Cited by 162 · see citing works
Loss of the neuroprotective factor sphingosine 1-phosphate early in Alzheimer’s disease pathogenesis
Couttas, T. A., Kain, N., Daniels, B., Lim, X. Y., Shepherd, C., Kril, J., Pickford, R., Li, H., Garner, B., & Don, A. S. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-9 · Cited by 161 · see citing works
Selective COX-2 Inhibitors and Dual Acting Anti-inflammatory Drugs: Critical Remarks
Bertolini, A., Ottani, A., & Sandrini, M. (2002) · Current Medicinal Chemistry · doi:10.2174/0929867024606650 · Cited by 158 · see citing works
Microglia in Alzheimer's Disease: Risk Factors and Inflammation
Katsumoto, A., Takeuchi, H., Takahashi, K., & Tanaka, F. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00978 · Cited by 138 · see citing works
Ceccom, J., Loukh, N., Lauwers‐Cancès, V., Touriol, C., Nicaise, Y., Gentil, C., Uro‐Coste, E., Pitson, S. M., Maurage, C., Duyckaerts, C. J., et al. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-12 · Cited by 136 · see citing works
Müller, N. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00375 · Cited by 117 · see citing works
Sphingosine 1-Phosphate Receptors and Metabolic Enzymes as Druggable Targets for Brain Diseases
Grassi, S., Mauri, L., Prioni, S., Cabitta, L., Sonnino, S., Prinetti, A., & Giussani, P. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00807 · Cited by 109 · see citing works
Fischer, I., Alliod, C., Martinier, N., Newcombe, J., Brana, C., & Pouly, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023905 · Cited by 102 · see citing works
Lipid metabolism in Alzheimer’s disease
Liu, Q., & Zhang, J. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-013-1410-3 · Cited by 101 · see citing works
Astrocytic ceramide as possible indicator of neuroinflammation
de Wit, N. M., den Hoedt, S., Martínez‐Martínez, P., Rozemüller, A. J. M., Mulder, M. T., & de Vries, H. E. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1436-1 · Cited by 100 · see citing works
Neuronal SphK1 acetylates COX2 and contributes to pathogenesis in a model of Alzheimer’s Disease
Lee, J. Y., Han, S. H., Park, M. H., Baek, B., Song, I., Choi, M.-K., Takuwa, Y., Ryu, H., Kim, S. H., He, X., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03674-2 · Cited by 97 · see citing works
Self-citationWu, Y., Mizugishi, K., Bektas, M., Sandhoff, R., & Proia, R. L. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn126 · Cited by 96 · see citing works
Lipid mediators in immune dysfunction after severe inflammation
Fullerton, J. N., O'Brien, A. J., & Gilroy, D. W. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.10.008 · Cited by 87 · see citing works
Jęśko, H. M., Stępień, A., Lukiw, W. J., & Strosznajder, R. P. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1286-3 · Cited by 85 · see citing works
Sphingosine 1-phosphate – A double edged sword in the brain
Indulekha, K., & van Echten‐Deckert, G. (2017) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2017.03.008 · Cited by 83 · see citing works
Sphingolipid Metabolism: A New Therapeutic Opportunity for Brain Degenerative Disorders
Pardo, A. D., & Maglione, V. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00249 · Cited by 73 · see citing works
Liu, L., Martin, R., & Chan, C. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.05.017 · Cited by 71 · see citing works
Anti-inflammatory mechanism of exogenous C2 ceramide in lipopolysaccharide-stimulated microglia
Jung, J.-S., Shin, K., Lee, Y.-M., Shin, J. A., Park, E., Jeong, J.-J., Kim, D., Choi, J. W., & Kim, H.-S. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.01.020 · Cited by 62 · see citing works
Aspirin-like molecules that covalently inactivate cyclooxygenase-2
Kalgutkar, A. S. S., Crews, B. C., Rowlinson, S. W., Garner, C., Seibert, K., Marnett, L. J., & Kresge, A. J. (1999) · Cited by 58 · see citing works
Neuroinflammation, the thread connecting neurological disease
Brambilla, R. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02009-9 · Cited by 56 · see citing works
Visual Features in Alzheimer’s Disease: From Basic Mechanisms to Clinical Overview
Cerquera-Jaramillo, M. A., Nava-Mesa, M. O., González-Reyes, R. E., Téllez-Conti, C., & de‐la‐Torre, A. (2018) · Neural Plasticity · doi:10.1155/2018/2941783 · Cited by 54 · see citing works
Assi, E., Cazzato, D., Palma, C. D., Perrotta, C., Clementi, E., & Cervia, D. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/309302 · Cited by 49 · see citing works
Erratum: Therapeutic strategies for Parkinson disease: beyond dopaminergic drugs
Charvin, D., Medori, R., Hauser, R. A., & Rascol, O. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.184 · Cited by 34 · see citing works
A Therapeutic Strategy for Alzheimer's Disease Focused on Immune-inflammatory Modulation
Kim, S. H., Noh, M., Kim, H.-J., Oh, K., Park, J., Lee, S.-G., Moon, Y., Kim, Y.-E., Bae, J. S., Jin, H. K., et al. (2019) · Dementia and Neurocognitive Disorders · doi:10.12779/dnd.2019.18.2.33 · Cited by 30 · see citing works
Self-citationAspirin triggers formation of anti-inflammatory mediators: New mechanism for an old drug.
Chiang, N., & Serhan, C. N. (2004) · PubMed · Cited by 21 · see citing works
Visan, I. (2017) · Nature Immunology · doi:10.1038/ni.3802 · Cited by 13 · see citing works
Sphingolipids in Neuroinflammation
Davies, L., Fassbender, K. C., & Walter, S. (2013) · Handbook of experimental pharmacology · doi:10.1007/978-3-7091-1511-4_21 · Cited by 12 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Reducing microglial lipid load enhances β amyloid phagocytosis in an Alzheimer’s disease mouse model
Wu, X., Miller, J. A., Lee, B. T. K., Wang, Y., & Ruedl, C. (2025) · Science Advances · doi:10.1126/sciadv.adq6038 · Cited by 67 · see citing works
“These abnormal changes in sphingolipid levels have been closely linked to neuroinflammatory disorders, as they play a crucial role in cell signaling and are, therefore, frequently discussed as potential therapeutic targets ( 45 , 46 ).”
Alpha-Synuclein and Lipids: The Elephant in the Room?
Sarchione, A., Marchand, A., Taymans, J., & Chartier‐Harlin, M. (2021) · Cells · doi:10.3390/cells10092452 · Cited by 67 · see citing works
Alteration in the Cerebrospinal Fluid Lipidome in Parkinson’s Disease: A Post-Mortem Pilot Study
Fernández‐Irigoyen, J., Cartas‐Cejudo, P., Iruarrizaga‐Lejarreta, M., & Santamaría, E. (2021) · Biomedicines · doi:10.3390/biomedicines9050491 · Cited by 66 · see citing works
Contribution of ceramides metabolism in psychiatric disorders
Bernal‐Vega, S., García‐Juárez, M., & Camacho‐Morales, A. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15759 · Cited by 57 · see citing works
Ayub, M., Jin, H.-K., & Bae, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147353 · Cited by 51 · see citing works
Self-citationBlank, M., Enzlein, T., & Hopf, C. (2022) · Scientific Reports · doi:10.1038/s41598-022-06894-1 · Cited by 48 · see citing works
Neuroimmunometabolism: A New Pathological Nexus Underlying Neurodegenerative Disorders
Mitra, S., Banik, A., Saurabh, S., Maulik, M., & Khatri, S. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.0998-21.2022 · Cited by 44 · see citing works
Arenas, Y. M., Balzano, T., Mincheva, G., Llansola, M., & Felipo, V. (2022) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12799 · Cited by 42 · see citing works
Potential neurotoxic activity of diverse molecules released by astrocytes
Murray, T. E., Richards, C. M., Robert-Gostlin, V. N., Bernath, A. K., Lindhout, I. A., & Klegeris, A. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.08.015 · Cited by 40 · see citing works
Lipids in Psychiatric Disorders: Functional and Potential Diagnostic Role as Blood Biomarkers
Zorkina, Y., Ushakova, V., Ochneva, A., Tsurina, A., Abramova, O., Savenkova, V., Goncharova, A., Alekseenko, I., Morozova, I., Riabinina, D., et al. (2024) · Metabolites · doi:10.3390/metabo14020080 · Cited by 36 · see citing works
Evolving Landscape of Parkinson’s Disease Research: Challenges and Perspectives
Tenchov, R., Sasso, J. M., & Zhou, Q. A. (2025) · ACS Omega · doi:10.1021/acsomega.4c09114 · Cited by 33 · see citing works
A Therapeutic Strategy for Alzheimer's Disease Focused on Immune-inflammatory Modulation
Kim, S. H., Noh, M., Kim, H.-J., Oh, K., Park, J., Lee, S.-G., Moon, Y., Kim, Y.-E., Bae, J. S., Jin, H. K., et al. (2019) · Dementia and Neurocognitive Disorders · doi:10.12779/dnd.2019.18.2.33 · Cited by 30 · see citing works
Self-citationSphingolipids and Diagnosis, Prognosis, and Organ Damage in Systemic Lupus Erythematosus
Harden, O. C., & Hammad, S. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.586737 · Cited by 28 · see citing works
Zhao, Y., Xu, J., Zhao, C., Bao, L., Wu, K., Feng, L., Sun, H., Shang, S., Hu, X., Sun, Q., et al. (2023) · Microbial Pathogenesis · doi:10.1016/j.micpath.2023.106225 · Cited by 25 · see citing works
Role of Body-Fluid Biomarkers in Alzheimer’s Disease Diagnosis
Nguyen, T. T., Ta, Q. T. H., Nguyen, T. K. O., Nguyen, T. K. O., & Giau, V. V. (2020) · Diagnostics · doi:10.3390/diagnostics10050326 · Cited by 25 · see citing works
Philipsen, M. H., Ranjbari, E., Gu, C., & Ewing, A. G. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202105004 · Cited by 21 · see citing works
Hwangbo, N., Zhang, X., Raftery, D., Gu, H., Hu, S., Montine, T. J., Quinn, J. F., Chung, K. A., Hiller, A., Wang, D., et al. (2022) · Metabolites · doi:10.3390/metabo12040277 · Cited by 22 · see citing works
Reemst, K., Broos, J. Y., Abbink, M. R., Cimetti, C., Giera, M. A., Kooij, G., & Kőrösi, A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.967437 · Cited by 22 · see citing works
Lee, H. J., Choe, K., Park, J. S., Khan, A., Kim, M. W., Park, T. J., & Kim, M. O. (2022) · Antioxidants · doi:10.3390/antiox11112107 · Cited by 20 · see citing works
Mu, C., Shao, K., Su, M., Guo, Y., Qiu, Y., Sun, R., Sun, S., Sun, Y., Liu, C., Wang, W., et al. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-00902-7 · Cited by 19 · see citing works
A scoping review on mycotoxin-induced neurotoxicity
Abia, W. A., Foupouapouognigni, Y., Njitoyap, H. P. N., Ngoungoure, L. V. N., Ntungwe, E. N., Salah‐Abbès, J. B., & Tchana, A. N. (2025) · Discover Toxicology · doi:10.1007/s44339-024-00013-7 · Cited by 20 · see citing works
Beger, A. W., Dudzik, B., Woltjer, R. L., & Wood, P. L. (2022) · Metabolites · doi:10.3390/metabo12020187 · Cited by 17 · see citing works
Sancho-Alonso, M., Arenas, Y. M., Izquierdo-Altarejos, P., Martínez-García, M., Llansola, M., & Felipo, V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417251 · Cited by 18 · see citing works
Peroxisomal defects in microglial cells induce a disease-associated microglial signature
Raas, Q., Tawbeh, A., Tahri-Joutey, M., Gondcaille, C., Keime, C., Kaiser, R., Trompier, D., Nasser, B., Leoni, V., Bellanger, E., et al. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1170313 · Cited by 16 · see citing works
Sun, X., Qu, T., Wang, W., Li, C., Yang, X., He, X., Wang, Y., Xing, G., Xu, X., Yang, L., et al. (2021) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.17026 · Cited by 16 · see citing works
Li, T., He, H., Zhang, E., Hu, F., Wang, Z., Xu, J., Zeng, M., & Peng, B. (2025) · Brain Pathology · doi:10.1111/bpa.70033 · Cited by 15 · see citing works
Alimajstorovic, Z., Mitchell, J., Yiangou, A., Hancox, T. P. M., Southam, A. D., Grech, O., Ottridge, R. S., Winder, C. L., Tahrani, A. A., Tan, T., et al. (2023) · Brain Communications · doi:10.1093/braincomms/fcad272 · Cited by 15 · see citing works
Ayala, V., Fontdevila, L., Rico-Rios, S., Povedano, M., Andrés‐Benito, P., Torres, P., Serrano, J. C. E., Pamplona, R., & Portero‐Otín, M. (2025) · Sclerosis · doi:10.3390/sclerosis3010008 · Cited by 15 · see citing works
Dysregulation of sphingolipid metabolism in pain
Wang, J., Zheng, G., Wang, L., Meng, L., Ren, J., Shang, L., Li, D., & Bao, Y. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1337150 · Cited by 14 · see citing works
Hepatic encephalopathy: investigational drugs in preclinical and early phase development
Balzano, T., Llansola, M., Arenas, Y. M., Izquierdo‐Altarejos, P., & Felipo, V. (2023) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2023.2277386 · Cited by 13 · see citing works
Sphingolipids and their role in health and disease in the central nervous system
Leal, A. F., Súarez, D. A., Echeverri-Peña, O. Y., Albarracín, S. L., Alméciga-Díaz, C. J., & Espejo-Mojica, A. J. (2022) · Advances in Biological Regulation · doi:10.1016/j.jbior.2022.100900 · Cited by 13 · see citing works
Alasmari, M. S., Alasmari, F. F., AlSharari, S. D., Alasmari, A. F., Ali, N., Ahamad, S. R., Alghamdi, A. M., Kadi, A. A., Hammad, A. M., Ali, Y. S. M., et al. (2024) · Toxics · doi:10.3390/toxics12080604 · Cited by 12 · see citing works
A Novel Sphingosine Kinase Inhibitor Suppresses Chikungunya Virus Infection
Oyewole, O. O., Dunnavant, K., Bhattarai, S., Kharel, Y., Lynch, K. R., Santos, W. L., & Reid, S. P. (2022) · Viruses · doi:10.3390/v14061123 · Cited by 12 · see citing works
Tsap, M. I., & Shcherbata, H. R. (2025) · Progress in Lipid Research · doi:10.1016/j.plipres.2025.101341 · Cited by 11 · see citing works
Gary, A. A., Prislovsky, A., Tovar, A., Locatelli, E. V. T., Felix, E. R., Stephenson, D., Chalfant, C. E., Lai, J. M., Kim, C. K., Mandal, N. A., et al. (2023) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.14343 · Cited by 10 · see citing works
Moseholm, K. F., Cronjé, H. T., Koch, M., Fitzpatrick, A. L., López, O. L., Otto, M. C. D. O., Longstreth, W. T., Hoofnagle, A. N., Mukamal, K. J., Lemaître, R. N., et al. (2024) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12623 · Cited by 8 · see citing works
Protective mechanisms against Alzheimer's disease in APOE3‐Christchurch homozygous astrocytes
Tian, X., Rivera, E. K., Hwang, I., Nikitina, A. A., Smith, J. A., Cho, Y. J., Sala‐Jarque, J., DuBose, A., Andriola, C., Gollan‐Myers, T., et al. (2025) · Alzheimer's & Dementia · doi:10.1002/alz.70589 · Cited by 7 · see citing works
Moustafa, E. A., El-Sayed, N. N. E., Fouad, M. A., Kerdawy, A. M. E., Ezzat, M. A. F., & Allam, H. A. (2025) · Drug Development Research · doi:10.1002/ddr.70132 · Cited by 7 · see citing works
Cocaine Induces Sex-Associated Changes in Lipid Profiles of Brain Extracellular Vesicles
Landfield, Q., Saito, M., Hashim, A., Canals‐Baker, S., Sershen, H. W., Levy, E., & Saito, M. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03395-x · Cited by 7 · see citing works
Lipidomics Analysis of Human HMC3 Microglial Cells in an In Vitro Model of Metabolic Syndrome
Chmielarz, M., Bromke, M. A., Olbromski, M., Środa-Pomianek, K., Frej−Mądrzak, M., Dzięgiel, P., & Sobieszczańska, B. (2024) · Biomolecules · doi:10.3390/biom14101238 · Cited by 6 · see citing works
Exogenous Antioxidants in Remyelination and Skeletal Muscle Recovery
Cabezas-Pérez, R., Ávila-Rodriguez, M., & Salazar, D. H. R. (2022) · Biomedicines · doi:10.3390/biomedicines10102557 · Cited by 6 · see citing works
Glycolipids in Parkinson's disease: beyond neuronal function
Spanos, F., & Deleidi, M. (2023) · FEBS Open Bio · doi:10.1002/2211-5463.13651 · Cited by 6 · see citing works
Zhang, N., Wang, G., Yang, L., Zhang, J., Yuan, Y., Ma, L., & Wang, Z. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112083 · Cited by 5 · see citing works
Sphingosine kinase-dependent regulation of pro-resolving lipid mediators in Alzheimer's disease
Ayub, M., Jin, H. K., & Bae, J. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2022.159126 · Cited by 5 · see citing works
Self-citationMeriau, P., Weill, L., Puccio, H. M., & Agulhon, C. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.16.589410 · Cited by 5 · see citing works
Wang, Z., Zhu, T., Ren, K., Ouyang, H., Pan, Q., Feng, Y., & Yang, S. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.121043 · Cited by 4 · see citing works
Metabolomic alterations in human brain microvascular endothelial cells induced by traumatic injury
Cela, E., Tweddell, D., Patterson, E. K., Daley, M., Cepinskas, G., & Fraser, D. D. (2025) · Metabolomics · doi:10.1007/s11306-025-02286-4 · Cited by 4 · see citing works
Relationship between sphingolipids-mediated neuroinflammation and alcohol use disorder
Cui, X., Li, J., Wang, C., Ishaq, H. M., Zhang, R., & Yang, F. (2023) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2023.173695 · Cited by 4 · see citing works
Mustafa, Y., Main, L. R., Mews, M., Janve, V. A., Hohman, T. J., Haines, J. L., Song, Y. E., Griswold, A. J., Pericak‐Vance, M. A., Scott, W. K., et al. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03698-5 · Cited by 3 · see citing works
Dong, Y., Wang, S., Qiu, Y., Su, Q., Sun, X., Li, M., & Li, J. (2025) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2025.107711 · Cited by 3 · see citing works
Sphingolipids in Emotional Well‐Being
Kalinichenko, L. S., Zoicas, I., Muehle, C., Kornhuber, J., & Müller, C. P. (2026) · Journal of Neurochemistry · doi:10.1111/jnc.70379 · Cited by 3 · see citing works
de Geus, T. J., Franken, G., Flinders, B., Cuypers, E., & Joosten, E. A. J. (2024) · Neuromodulation Technology at the Neural Interface · doi:10.1016/j.neurom.2024.09.005 · Cited by 2 · see citing works
Sun, S., Hu, S., Wang, Y., Sun, M., & Zhao, L. (2025) · Journal of Pain Research · doi:10.2147/jpr.s536220 · Cited by 2 · see citing works
Tripathi, U., Stern, Y., Dagan, I., Nayak, R., Romanovsky, E., Zittan, E., & Stern, S. (2025) · Biology · doi:10.3390/biology14101433 · Cited by 2 · see citing works
Bai, H., Zeng, H.-M., Zhang, Q., Hu, Y.-Z., & Deng, F. (2024) · World Journal of Clinical Cases · doi:10.12998/wjcc.v12.i6.1063 · Cited by 2 · see citing works
Minamihata, T., Takano-Kawabe, K., & Moriyama, M. (2024) · Neurology International · doi:10.3390/neurolint16040054 · Cited by 2 · see citing works
Miranda, O., Qi, X., Brannock, M. D., Whitworth, R., Kosten, T. R., Ryan, N. D., Haas, G. L., Kirisci, L., & Wang, L. (2024) · Biomedicines · doi:10.3390/biomedicines12122772 · Cited by 2 · see citing works
Philipsen, M. H., Ranjbari, E., Gu, C., & Ewing, A. G. (2021) · Angewandte Chemie · doi:10.1002/ange.202105004 · Cited by 2 · see citing works
Yu, H. Q., Dejizhuoga, Huang, W., Wang, D., Gamaquzhen, Jia, X., & Feng, H. (2022) · Emergency Medicine International · doi:10.1155/2022/6716143 · Cited by 2 · see citing works
RetractedZhao, F., Li, P., Deng, F., Wang, J., Cheng, Y., Pei, K., Wang, Y., & Wang, Y. (2023) · Chemistry & Biodiversity · doi:10.1002/cbdv.202200920 · Cited by 1 · see citing works
DeVeaux, S. A., Vyshnya, S., Propsom, K., Gbotosho, O. T., Singh, A. S., Horning, R. Z., Sharma, M., Jegga, A. G., Niu, L., Botchwey, E. A., et al. (2024) · Experimental Biology and Medicine · doi:10.3389/ebm.2024.10361 · Cited by 1 · see citing works
An exploratory study of plasma ceramides in comorbidities in Down syndrome
Worley, G., Byeon, S. K., Smith, P. B., Hart, S. J., Young, S. P., Pandey, A., & Kishnani, P. S. (2023) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.63325 · Cited by 1 · see citing works
Circulating sphingolipids and subclinical brain pathology: the cardiovascular health study
Moseholm, K. F., Horn, J. W., Fitzpatrick, A. L., Djoussé, L., Longstreth, W. T., Jr., López, O. L., Hoofnagle, A. N., Jensen, M. K., Lemaître, R. N., & Mukamal, K. J. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1385623 · Cited by 1 · see citing works
Dhanabalan, A. K., Velmurugan, D., Haribabu, J., & Gunasekaran, K. (2024) · Molecular Diversity · doi:10.1007/s11030-024-10997-4 · Cited by 1 · see citing works
Leal, A. F., Súarez, D. A., Echeverri-Peña, O. Y., Albarracín, S. L., Alméciga-Díaz, C. J., & Espejo-Mojica, A. J. (2021) · Preprints.org · doi:10.20944/preprints202104.0161.v1 · Cited by 1 · see citing works
Liu, Y., Pizzato, J., & Larrouy-Maumus, G. J. (2023) · doi:10.1002/9781119814085.ch15 · Cited by 1 · see citing works
Analysis of Immune Dysfunction and Predictors of Poor Prognosis in Patients with Alzheimer's DiseasePreprint
Liu, L., Zeng, H., Zhang, Q., Deng, F., & Bai, H. (2021) · Research Square · doi:10.21203/rs.3.rs-839108/v1
Japanese Encephalitis Virus-Induced Peripheral Neuropathy in the Rat ModelPreprint
Zhang, N., Yuan, Y., Yang, L., Wang, G., Yang, H., Wang, Z., Li, X., Yu, L., Zhang, D., Wang, H., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1324807/v1
Sphingolipids as Oxygen Sensors and Major Orchestrators of Cellular Responses to Hypoxia
Mrad, M., Dargham, T. B., Moumneh, M. B., & Dbaibo, G. S. (2022) · Springer eBooks · doi:10.1007/978-3-030-80962-1_98-1
DeVeaux, S. A., Vyshnya, S., Propsom, K., Gbotosho, O. T., Singh, A. S., Horning, R. Z., Sharma, M., Jegga, A. G., Niu, L., Botchwey, E. A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.24.577074
Metabolic Characteristics and Biomarker Screening of Poultry Eggs from Different SpeciesPreprint
li, H., Qin, S., Li, J., Zhao, X., Liang, J., Li, X., Zhang, A., Xu, L., Tang, D., & Li, F. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5253493
Sphingolipids as Oxygen Sensors and Major Orchestrators of Cellular Responses to Hypoxia
Mrad, M., Dargham, T. B., Moumneh, M. B., & Dbaibo, G. S. (2025) · Springer eBooks · doi:10.1007/978-3-032-00761-2_98
Banik, S. P., Ghosh, R. B., Kaur, K., Bagchi, M., & Bagchi, D. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33355-2.00020-7
Causality of blood metabolites and narcolepsy type 1: A Mendelian randomization study
Shen, B., Jin, H., Li, W., Yang, J., & Song, J. (2025) · Medicine · doi:10.1097/md.0000000000046307
Self-citationInteractions propriocepteurs et cellules satellites gliales dans l’ataxie de Friedreich
Meriau, P. (2022) · theses.fr (ABES) · doi:10.70675/7b9be03cz60c9z4774z9d6cz72cd5c3f9788
Sphingosine-1-Phosphate as an Immune-Metabolic Biomarker in Neurodegenerative Diseases
Kim, S. H., Jin, H. K., & Bae, J. (2026) · Journal of Clinical Neurology · doi:10.3988/jcn.2026.0158
Self-citationThe riddle of sphingolipid structure-function relationship in the nervous system
Muñoz-Gil, S., & Spassieva, S. D. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.113258
The critical role of ceramide in mental health and psychiatric diseases
Xu, X., Li, H., Zhu, Y., Fu, X., Hu, Q., & Dong, X. (2026) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2026.109093
Yang, B. S. K., Ahmad, Y., Chen, H., Khanduja, S., Soulé, Z., Leal, R., Choi, H. A., McCullough, L. D., Dinh, K., Akkanti, B. H., et al. (2026) · Cells · doi:10.3390/cells15171593
Enzyme−Targeted Therapeutics for Neurological Disorders
Massignan, L., Lokesh, K., Ziadat, S., Uehling, D., Weaver, D. F., & Reed, M. A. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c01274
Hoffmann, A., Allwright, M., Guennewig, B., Rohleder, C., Jieu, B., Koethe, D., Dammann, I., del Castillo, A. A., Mueller, J. K., Enning, F., et al. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03933-5
- Authors
- Lee, J. Y., Jin, H. K., & Bae, J.-S.
- Affiliations
- Kyungpook National University (KR)
- Corresponding author
- Lee, Ju Youn
- Venue
- BMB Reports
- Published
- 2020-01-31
- Volume
- 53
- Issue
- 1
- Pages
- 28-34
- ISSN
- 1976-6696 (ISSN-L)
- 1976-670X
- PMC
- PMC6999823
- OpenAlex
- W2997449152
- Cited by
- 80
- References
- 64
- Citations by year
- 2026: 6 · 2025: 19 · 2024: 15 · 2023: 12 · 2022: 16 · 2021: 9 · 2020: 2 · 2019: 1
- FWCI
- 3.16
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- BMB Reports (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- National Research Foundation of Korea (2017R1A4A1015652, 2018M3C7A1056513)
- Ministry of Science ICT and Future Planning
- Korea Health Industry Development Institute
- Ministry of Health and Welfare (HI16C2131)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Physiology › Lysosomal Storage Disorders Research
- Keywords
- sphingolipids, neuroinflammation, ceramide, sphingosine kinase, Alzheimer's disease, Parkinson's disease, inflammatory mediators, therapeutic target, diagnostic biomarkers, central nervous system
- MeSH terms
- Sphingosine Kinase, Alzheimer Disease, Central Nervous System, Ceramides, Humans, Inflammation, Lysophospholipids, Parkinson Disease, Sphingolipids, Sphingosine, Signal Transduction, Microglia, Phosphotransferases (Alcohol Group Acceptor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review